Related Experiment Video
Updated: Mar 25, 2026

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
Published on: April 22, 2015
Sleep Difficulties and Medications in Children With Autism Spectrum Disorders: A Registry Study
Beth A Malow1, Terry Katz2, Ann M Reynolds2
1Sleep Disorders Division, Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee; beth.malow@vanderbilt.edu.
Insights
Sleep difficulties affect 71% of children with autism spectrum disorder (ASD), impacting behavior. Medications are common but linked to poorer outcomes, highlighting the need for better interventions.
Area of Science:
- Pediatric Sleep Medicine
- Autism Spectrum Disorder Research
- Clinical Psychology
Background:
- Sleep difficulties are prevalent in children with autism spectrum disorder (ASD).
- These sleep issues significantly impact children's daytime behavior and quality of life.
- Understanding sleep patterns and medication use in ASD is crucial for effective management.
Purpose of the Study:
- To determine the prevalence of sleep difficulties in children with ASD.
- To analyze patterns of sleep medication use in this population.
- To investigate the relationship between sleep problems, medication, and daytime behavior.
Main Methods:
- Analysis of data from 1518 children aged 4-10 years in the Autism Speaks Autism Treatment Network Registry.
- Utilized parent-completed questionnaires (Children's Sleep Habits Questionnaire) and clinician-completed forms.
- Examined sleep diagnoses and prescribed sleep medications.
Main Results:
- 71% of children with ASD reported clinically significant sleep problems.
- Sleep diagnoses were less frequent (30%) than reported sleep difficulties.
- Medications were used by 46% of children with a sleep diagnosis, with melatonin being most common. Children on sleep medication showed worse daytime behavior and quality of life.
Conclusions:
- Parental concerns about sleep in ASD may be underreported in clinical settings, necessitating improved screening.
- Current sleep medications in children with ASD are associated with adverse effects and poorer outcomes.
- There is a critical need for evidence-based sleep interventions for children with autism spectrum disorder.
Objectives:
Sleep difficulties are common in children with autism spectrum disorders, with wide-ranging effects on the child's daytime behavior. We reviewed data within our Autism Speaks Autism Treatment Network Registry to determine the prevalence of sleep difficulties and patterns of medication use.
Methods:
Data from 1518 children ages 4 to 10 years were analyzed to determine the number of children documented to have sleep difficulties by parent-completed questionnaires and clinician-completed forms and how these findings related to the use of sleep medications.
Results:
The Children's Sleep Habits Questionnaire total score was ≥41 (associated with clinically significant sleep problems in past research) in 71% of children. The prevalence of sleep diagnoses was less frequent (30% of children aged 4-10 years; P < .0001). Medications for sleep were prescribed in 46% of 4- to 10-year-olds given a sleep diagnosis. The most common medication used for sleep was melatonin followed by α-agonists, with a variety of other medications taken for sleep (anticonvulsants, antidepressants, atypical antipsychotics, and benzodiazepines). Children taking medications for sleep had worse daytime behavior and pediatric quality of life than children not taking sleep medications.
Conclusions:
Parent concerns about sleep may not be reflected in the information gathered during a clinic visit, supporting the need to develop screening practice pathways for sleep in autism spectrum disorders. Furthermore, many medications taken for sleep have adverse effects, supporting the need for evidence-based interventions in this population.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Nightmares and Night Terrors
Nightmares...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Insomnia
Multiple factors contribute...

